Cases Of Respiratory Disease Research Articles

A Study on Serum Vitamin D Level in Patients Suffering from Various Pulmonary Disorders

Vitamin D is a critical nutrient for human health. However, our environment, lifestyle and genetic makeup can significantly impact the efficacy of vitamin D production in the body. Unfortunately, our diets do not provide us with sufficient vitamin D, leading to a variety of health issues. Vitamin D also has a pivotal role in the development of pulmonary diseases. Hence this study was done to estimate vitamin D levels in patients suffering from various pulmonary disorders. This is a cross-sectional type of study conducted at a tertiary care centre with a sample size of 160 consisting of 80 cases of respiratory diseases with 80 apparently healthy attendees for a period of 1 year. We found that vitamin D levels were deficient (16.95ng/ ml) in pulmonary disease patients as compared to their apparently healthy attendees(20.69). Patients with infective aetiology i.e., Tuberculosis, community-acquired pneumonia, and bronchiectasis had a much lower value of vitamin D (10.72 ng/ml) as compared to other patients with noninfective aetiology (19.43 ng/ml). Our study shows an inverse relationship between blood vitamin D levels and Body Mass Index and found direct association with occupation and smoking history. However, no link was discovered with gender or geography. This study’s findings add to the growing body of information on the factors related to vitamin D status.

Hygienic aspects of the implementation of the federal project "clean air" in the Omsk city

The aim of the work was the hygienic assessment of the atmospheric air quality and health risks to the population of Omsk city arising under the influence of chemical pollution of atmospheric air at the current stage of realization of the federal project "Clean Air".
 Material and methods. For hygienic assessment of atmospheric air quality in the territory of the city of Omsk the results of socio-hygienic monitoring and the national environmental observation system of atmospheric air pollution for the period 2017-2022 were used. Health risk assessment and calculation of the additional number of diseases under the influence of pollutants were carried out in accordance with the Guidelines for health risk assessment of exposure to chemical pollutants (R 2.1.10.3968-23).
 Results. The volumes of uncaptured air pollutant emissions from stationary sources in 2022 decreased by 21.9% compared to the baseline year 2017, from motor vehicles - by 43.6%. The level of carcinogenic risk was above the permissible value and was assessed as alarming, with an increase of 28.7% between 2017 and 2022. The average annual respiratory hazard index was assessed as high. Comparative analysis of the values of non-carcinogenic risks in 2017 and in 2022 for the population of Omsk showed an increase in harmful effects on the respiratory organs (2.5% increase), the immune system (1.6-fold increase) and the central nervous system (1.7-fold increase). At the same time, the risks to the cardiovascular system decreased, and the overall systemic effect of toxicants was reduced. As a result of long-term chronic excess formaldehyde air pollution, the mean annual population risk over the entire follow-up time was 2377.4 (CI 1802.6-2992.4; 95%) cases of additional respiratory diseases per year detected during primary and repeat patient visits.
 Conclusion. The advanced achievement of the targets of the Federal Program "Clean Air" on emissions reduction has not yet resulted in a commensurate improvement of the atmospheric air quality from the hygienic point of view. Carcinogenic risks to public health are decreasing, but remain above permissible levels. Non-carcinogenic risks for a number of substances form additional morbidity. It is necessary to develop additional interdepartmental measures to reduce emissions, primarily formaldehyde and benz/a/pyrene, to provide preventive protection of public health, especially vulnerable groups living in the city.

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

BackgroundRespiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under clinical investigation.MethodsIn this ongoing, randomized, double-blind, placebo-controlled, phase 2–3 trial, we randomly assigned, in a 1:1 ratio, adults 60 years of age or older to receive one dose of mRNA-1345 (50 μg) or placebo. The two primary efficacy end points were the prevention of RSV-associated lower respiratory tract disease with at least two signs or symptoms and with at least three signs or symptoms. A key secondary efficacy end point was the prevention of RSV-associated acute respiratory disease. Safety was also assessed.ResultsOverall, 35,541 participants were assigned to receive the mRNA-1345 vaccine (17,793 participants) or placebo (17,748). The median follow-up was 112 days (range, 1 to 379). The primary analyses were conducted when at least 50% of the anticipated cases of RSV-associated lower respiratory tract disease had occurred. Vaccine efficacy was 83.7% (95.88% confidence interval [CI], 66.0 to 92.2) against RSV-associated lower respiratory tract disease with at least two signs or symptoms and 82.4% (96.36% CI, 34.8 to 95.3) against the disease with at least three signs or symptoms. Vaccine efficacy was 68.4% (95% CI, 50.9 to 79.7) against RSV-associated acute respiratory disease. Protection was observed against both RSV subtypes (A and B) and was generally consistent across subgroups defined according to age and coexisting conditions. Participants in the mRNA-1345 group had a higher incidence than those in the placebo group of solicited local adverse reactions (58.7% vs. 16.2%) and of systemic adverse reactions (47.7% vs. 32.9%); most reactions were mild to moderate in severity and were transient. Serious adverse events occurred in 2.8% of the participants in each trial group.ConclusionsA single dose of the mRNA-1345 vaccine resulted in no evident safety concerns and led to a lower incidence of RSV-associated lower respiratory tract disease and of RSV-associated acute respiratory disease than placebo among adults 60 years of age or older. (Funded by Moderna; ConquerRSV ClinicalTrials.gov number, NCT05127434.)

Time trend of respiratory viruses before and during the COVID-19 pandemic in severe acute respiratory virus infection in the Sultanate of Oman between 2017 and 2022.

Severe acute respiratory illness (SARI) is a potentially lethal condition, necessitating thorough medical care. COVID-19 underscored the SARI threat, but other high-risk pathogens require monitoring alongside SARS-CoV-2. Oman instituted a comprehensive testing system to gauge the prevalence of these pathogens between 2017 and 2021, aiding resource allocation and public health responses to potential respiratory pathogen outbreaks. Samples from SARI cases admitted to ICU were tested for pathogens using the Fast-Track Diagnostic (FTD) molecular assay, a respiratory virus panel (RVP) that tests for 21 pathogens, including 20 viruses, by qPCR. Between 2017 and 2022, ~30 000 samples were analysed using the RVP panel. Among SARI patients, 8%-42% tested positive for respiratory pathogens, with 4% showing multiple infectious agents, especially in children under 10. A drop in positivity during 2020-2021 can be attributed to SARS-CoV-2 control measures, followed by a rebound in infections in early 2022. The COVID-19 pandemic heightened awareness of respiratory pathogens' spread without adequate control measures. Influenza A/B, human rhinoviruses and respiratory syncytial virus constituted over 50% of severe acute respiratory illness cases in Oman over the past 5years. During the pandemic, the incidence of these infections significantly declined, demonstrating the efficacy of COVID-19 prevention measures in reducing spread of other pathogens.

Neglected bacterial infections associated to bovine respiratory disease in lactating cows from high-yielding dairy cattle herds.

Bovine respiratory disease (BRD) is a multifactorial and predominantly multietiological disease that affects dairy cattle herds worldwide, being more frequent in young animals. The occurrence of BRD was investigated in lactating cows from two high-yielding dairy herds in southern Brazil. To determine the etiology of the clinical cases of acute respiratory disease, nasal swab samples were collected from cows with clinical signs of BRD and evaluated using PCR and RT-PCR for nucleic acid detection of the main BRD etiological agents, including Mycoplasma bovis, Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, bovine respiratory syncytial virus, bovine coronavirus, bovine viral diarrhea virus, bovine alphaherpesvirus 1, and bovine parainfluenza virus 3. Only three microorganisms (M. bovis, H. somni, and P. multocida) were identified in both single and mixed infections. We concluded that 40.0% of the cows were infected with M. bovis and 75.0% with H. somni in herd A. Considering both single and mixed infections, the analyses performed in herd B showed that 87.5%, 25.0%, and 50.0% of the cows were infected with M. bovis, H. somni, and P. multocida, respectively. M. bovis and H. somni are considered fastidious bacteria and laboratory diagnosis is neglected. Subsequently, most clinical cases of mycoplasmosis and histophilosis in cattle remain undiagnosed. This study demonstrates the importance of M. bovis and H. somni infections in adult cows with BRD. These results highlight the importance of including these bacteria in the group of etiological agents responsible for the occurrence of BRD in cattle, especially in adult cows with unfavorable immunological conditions, such as recent calving and peak lactation.

Predominance of low pathogenic avian influenza virus H9N2 in the respiratory co-infections in broilers in Tunisia: a longitudinal field study, 2018–2020

Respiratory diseases are a health and economic concern for poultry production worldwide. Given global economic exchanges and migratory bird flyways, respiratory viruses are likely to emerge continuously in new territories. The primary aim of this study was to investigate the major pathogens involved in respiratory disease in Tunisian broiler poultry and their epidemiology. Between 2018 and 2020, broilers farms in northeastern Tunisia were monitored, and 39 clinically diseased flocks were sampled. Samples were screened for five viral and three bacterial respiratory pathogens using a panel of real-time PCR assays. The reemergence of H9N2 low pathogenic avian influenza virus (LPAIV) in commercial poultry was reported, and the Northern and Western African GI lineage strain was typed. The infectious bronchitis virus (IBV) GI-23 lineage and the avian metapneumovirus (aMPV) subtype B also were detected for the first time in broilers in Tunisia. H9N2 LPAIV was the most detected pathogen in the flocks tested, but rarely alone, as 15 of the 16 H9N2 positive flocks were co-infected. Except for infectious laryngotracheitis virus (ILTV), all of the targeted pathogens were detected, and in 61% of the respiratory disease cases, a combination of pathogens was identified. The major combinations were H9N2 + aMPV (8/39) and H9N2 + IBV (6/39), showing the high contribution of H9N2 LPAIV to the multifactorial respiratory diseases. This field survey provided evidence of the emergence of new respiratory viruses and the complexity of respiratory disease in Tunisia. A comprehensive and continuous surveillance strategy therefore is needed to better control respiratory pathogens in Tunisia.

Interventions to reduce camel and small ruminant young stock morbidity and mortality in Ethiopia.

Morbidity and mortality of young stock is a challenge for livestock producers globally. In Ethiopia, where camels and small ruminants (sheep and goats) are essential smallholder and pastoral livestock, young stock losses can cause severe consequences to livelihoods. This pilot study, part of a Government-led Young Stock Mortality Reduction Consortium project, was undertaken to identify and evaluate interventions to reduce young stock mortality in mixed crop-livestock and pastoral production systems in Ethiopia. Pastoralists and mixed crop-livestock farmers were enrolled by convenience sampling across four regions. Households were sampled with questionnaire surveys to establish baseline mortality risk and prevalence of diarrhoea and respiratory disease in animals younger than one year, and followed longitudinally over a one-year period, with final evaluations conducted from March to July 2020. Mortality risk and prevalence of diarrhoea and respiratory disease before and after implementation were compared using Poisson regression models including household as random effect. Prior to intervention, median camel mortality, prevalence of diarrhoea, and respiratory disease across production systems in the different households was 0.4, 0.44 and 0.2, respectively. This compared to median pastoralist small ruminant mortality risk and prevalence of diarrhoea and respiratory disease of 0.45, 0.32 and 0.18, respectively. Post-intervention, median camel mortality, prevalence of diarrhoea and respiratory disease dropped to 0.1, 0.08 and 0. Similarly, more than half of the small ruminant households reported no mortality, and no cases of diarrhoea or respiratory disease. In camels, rate ratios of mortality risk, prevalence of diarrhoea, and respiratory disease post-intervention compared to the baseline were 0.41, 0.41 and 0.37. In small ruminants, rate ratios were 0.33, 0.35 and 0.46. All reductions were statistically significant (p<0.01). Generally, pastoralists experienced higher mortality and disease prevalence compared to mixed crop-livestock smallholders, and the effect of intervention was slightly higher in pastoralist households. The pilot study findings demonstrated highly significant reductions in mortality and risk of diarrhoea and respiratory disease post-interventions. However, not all households benefitted from the interventions, with a few households reporting increased mortality and morbidity. Many households had very few animals which made it challenging to measure impact and the study was conducted over a single year, without a control group, so between year effects could not be accounted for in the reductions observed. These findings should contribute to improved livestock productivity in Ethiopia.

Causes, Impacts and Policy Implications of Carbon Monoxide Air Pollution in Third World Countries

Globally, countries are grappling with significant complications, notably air pollution and global warming. One of the hazardous substances contributing to this problem is carbon monoxide (CO), a deadly, odorless, and colorless gas released through both natural processes and human activities. Among developing nations, Guatemala has experienced rapid and dramatic urbanization over the last decades. As a result of this urbanization, a disturbing correlation exists between increased respiratory disease cases and the presence of carbon monoxide in the air. Guatemalans face a surplus of health issues due to air pollution, including asthma, upper respiratory disorders, and chronic obstructive pulmonary disease (COPD). These health risks are not solely confined to urbanized areas but also extend into rural regions where Guatemalans use open fires inside their homes for cooking.&#x0D; Unfortunately, current laws governing air quality oversight and management in Guatemala are inadequate as they fail to safeguard and benefit the well-being of their people. To assess the extent of air pollution in Guatemala, the study measured carbon monoxide levels in parts per million (ppm) using EasyLog USB at various locations and Guatemala City, the nation's most populous urban city. Data was collected over six days, revealing alarmingly high levels of CO, specifically in densely populated areas with significant vehicular activity. The lack of proper ventilation systems and environmental regulations in these areas contributes to the persistence of elevated CO levels. This study's primary objective is to highlight CO poisoning issues in developing countries like Guatemala, emphasizing the urgent need for the national government to implement appropriate legislation and monitoring systems to mitigate its adverse effects. By taking decisive action, Guatemala can further reduce and protect its people from the detrimental impact of air pollution and ultimately work towards creating a healthier, more sustainable environment.

Peramalan Jumlah Penderita Jenis Penyakit Utama Di Kota Surabaya Menggunakan Metode Autoregressive Integrated Moving Average (ARIMA)

The decline in Covid-19 pandemic cases over the past few months before 2023 not only reduced Indonesia's challenges in dealing with other types of diseases. Surabaya city itself has health issues that need to be addressed, as indicated by an increase in several diseases in 2022. One attempt to handle disease cases is to predict the future case numbers to anticipate actions early on. By using data on the number of cases of Respiratory System Diseases during the year 2022, this data will be used to predict the number of cases in the coming months in 2023 by creating a variation of a univariate ARIMA forecasting model. Therefore, the research results show forecasted data that tend to increase when viewed from the analysis and the plotted graph of the forecast results.

Spatio-temporal evaluation of respiratory disease based on the information provided by patients admitted to a medical college hospital in Bangladesh using geographic information system

In Bangladesh respiratory illnesses are one of the leading risk factors for death and disability. Limited access to healthcare services, indoor and outdoor air pollution, large-scale use of smoking materials, allergens, and lack of awareness are among the known leading factors contributing to respiratory illness in Bangladesh. Key initiatives taken by the government to handle respiratory illnesses include, changing of respiratory health policy, building awareness, enhancing healthcare facility, and promoting prevention measures. Despite all these efforts, the number of individuals suffering from respiratory diseases has increased steadily during the recent years. This study aims at examining the distribution pattern of respiratory diseases over space and time using Geographic Information System, which is expected to contribute to the better understand of the factors contributing to respiratory illness development. To achieve the aims of the study two interviews were conducted among patients with respiratory sickness in the medicine and respiratory medicine units of Rajshahi Medical College Hospital between January and April of 2019 and 2020 following the guidelines provided by the Ethics Committee, Department of Geography and Environmental Studies, University of Rajshahi, Bangladesh (ethical approval reference number: 2018/08). Principal component extraction and spatial statistical analyses were performed to identify the key respiratory illnesses and their geographical distribution pattern respectively. The results indicate, during January–February the number of patients was a lot higher compared to March–April. The patients were hospitalized mainly due to four respiratory diseases (chronic obstructive pulmonary disease, asthma, pneumonia, and pulmonary hypertension). Geographical distribution pattern of respiratory disease cases also varied considerably between the years as well as months of the years. This information seems reasonable to elucidate the spatio-temporal distribution of respiratory disease and thus improve the existing prevention, control, and cure practices of respiratory illness of the study area. Approach used in this study to elicit spatio-temporal distribution of repertory disease can easily be implemented in other areas with similar geographical settings and patients’ illness information from hospital.

Investigation and analysis of children's behavior and outpatient number of respiratory diseases in Shanghai before and after the COVID-19 pandemic

ObjectiveAlterations in behavioral habits of children were analyzed in Shanghai in the winters prior to and following the COVID-19 pandemic, with the aim of assisting in the prevention of children's respiratory diseases in the post-pandemic era. MethodThis cross-sectional survey was conducted via an offline questionnaire from January 1 to February 28, 2021. The behavioral habits of Shanghainese children in different age groups during the winter of 2019 and 2020 were statistically analyzed using the SPSS 25.0 software. The parameters surveyed and analyzed included the frequency of outdoor activities, self-protection measures (frequency of wearing masks and washing hands after going out), travel history, time to visit since symptom onset, and influenza vaccination status. Lastly, the number of cases of respiratory diseases in the pediatric outpatient department of our hospital was analyzed during the same period. ResultA total of 1816 questionnaires were investigated and analyzed, and the results revealed that self-protection measures were significantly enhanced in children of all age groups after the COVID-19 pandemic breakout compared with those before the pandemic, whereas the frequency of outdoor activities and traveling were reduced. In the age group over 3 years old, the time to visit since symptom onset was shorter, and the influenza vaccination rate increased following the pandemic. During the same period, the number of cases of children with respiratory diseases in our outpatient department was significantly decreased compared with that prior to the COVID-19 pandemic. ConclusionThe COVID-19 pandemic has had a significant impact on self-protection measures, outdoor activities, and other children's behaviors in all age groups in Shanghai. These changes in habits were correlated with a lower incidence and transmission of respiratory diseases in children. Overall, this study lays a theoretical basis for the prevention of childhood illnesses in the post-pandemic era.

Assessing the Intense Influenza A(H1N1)pdm09 Epidemic and Vaccine Effectiveness in the Post-COVID Season in the Russian Federation.

The COVID-19 pandemic had a profound impact on influenza activity worldwide. However, as the pandemic progressed, influenza activity resumed. Here, we describe the influenza epidemic of high intensity of the 2022-2023 season. The epidemic had an early start and peaked in week 51.2022. The extremely high intensity of the epidemic may have been due to a significant decrease in herd immunity. The results of PCR-testing of 220,067 clinical samples revealed that the influenza A(H1N1)pdm09 virus dominated, causing 56.4% of positive cases, while A(H3N2) influenza subtype accounted for only 0.6%, and influenza B of Victoria lineage-for 34.3%. The influenza vaccine was found to be highly effective, with an estimated effectiveness of 92.7% in preventing admission with laboratory-confirmed influenza severe acute respiratory illness (SARI) cases and 54.7% in preventing influenza-like illness/acute respiratory illness (ILI/ARI) cases due to antigenic matching of circulated viruses with influenza vaccine strains for the season. Full genome next-generation sequencing of 1723 influenza A(H1N1)pdm09 viruses showed that all of them fell within clade 6B.1A.5.a2; nine of them possessed H275Y substitution in the NA gene, a genetic marker of oseltamivir resistance. Influenza A(H3N2) viruses belonged to subclade 3C.2a1b.2a.2 with the genetic group 2b being dominant. All 433 influenza B viruses belonged to subclade V1A.3a.2 encoding HA1 substitutions A127T, P144L, and K203R, which could be further divided into two subgroups. None of the influenza A(H3N2) and B viruses sequenced had markers of resistance to NA inhibitors. Thus, despite the continuing circulation of Omicron descendant lineages, influenza activity has resumed in full force, raising concerns about the intensity of fore coming seasonal epidemics.

Impact of Air Pollution on Respiratory Diseases in Typical Industrial City in the North China Plain

Air pollution can lead to the elevated incidence of various respiratory diseases, seriously endangering the health of urban residents. To better comprehend the association between urban air pollution and respiratory disease incidence, this study focused on Xinxiang City, a typical industrial city in the North China Plain, as the research object. By analyzing monthly air pollution index concentrations from 2018 to 2021 and confirmed cases of respiratory diseases, and incorporating meteorological factors as reference points, we conducted a correlation analysis between disease data and pollutant concentrations. We then constructed a Poisson regression model to obtain maximum likelihood estimates, which were used to predict the quantitative relationship between the incidence of respiratory diseases and air pollution indicators. The results showed that an increase of 1 μg/m³ in the average mass concentration of PM2.5, PM10, NO2, and SO2 in ambient air was associated with an elevated incidence of respiratory diseases by 0.2–1.4%, 0.7–1.6%, 3.7–8.2%, and 0.5–2.3%, respectively; meanwhile, a monthly mean mass concentration of CO increased by 1 mg/m³ led to a rise in pulmonary tuberculosis incidence by 2.9%. Additionally, based on health risk data following exposure to air pollution in Xinxiang City, it was confirmed that the impact of respiratory diseases as measured by the air quality composite index was more applicable than the single pollution index. Furthermore, there was a significant association between air pollution and the incidence of respiratory diseases.

In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.

This study determined the in vitro activity of finafloxacin against panels of bacterial strains, representative of those associated with infection in cystic fibrosis patients and predominately isolated from clinical cases of respiratory disease. Many of these isolates were resistant to various antimicrobials evaluated including the aminoglycosides, cephalosporins, carbapenems and fluoroquinolones. Broth microdilution assays were performed at neutral and acidic pH, to determine antimicrobial activity. Finafloxacin demonstrated superior activity at reduced pH for all of the bacterial species investigated, highlighting the requirement to determine the activity of antimicrobials in host-relevant conditions.

Antimicrobial susceptibility and molecular characteristics of Mycoplasma bovis isolated from cases of bovine respiratory disease in Australian feedlot cattle

To date, antimicrobial susceptibility has not been reported for Australian Mycoplasma bovis isolates. This study determined minimal inhibitory concentrations (MICs) for 12 different antimicrobials against Australian M. bovis isolates and used whole genome sequencing to screen those showing high macrolide MICs for point mutations in target genes. Most lung tissue/swab samples from bovine respiratory disease cases (61/76, 80.3%) tested positive for M. bovis. A set of 50 representative isolates (50/61, 82.0%) that showed adequate growth, was used for MIC testing. Uniformly, low MIC values were confirmed for enrofloxacin (≤ 4 μg/mL), florfenicol (≤ 8 μg/mL), gamithromycin (≤ 2 μg/mL), spectinomycin (≤ 4 μg/mL), tetracycline (≤ 8 μg/mL), tiamulin (≤ 4 μg/mL), and tulathromycin (≤ 0.5 μg/mL). A small proportion (10%) of isolates exhibited high MICs (≥ 32 μg/mL) for tildipirosin, tilmicosin, tylosin, and lincomycin, which were above the epidemiological cut-off values for each antimicrobial (≥ 4 μg/mL). These isolates, originating from three Australian states, underwent whole genome sequencing/multilocus sequencing typing and were compared with the reference strain PG45 to investigate mutations that might be linked with the high macrolide/lincosamide MICs. All five belonged to ST52 and two macrolide associated mutations were identified within the 23 S rRNA gene (A2058G in two sequenced isolates and G748A in all sequenced isolates). Four additional 23 S rRNA gene mutations did not appear to be linked to macrolide resistance. Whilst the majority of Australian M. bovis isolates appear susceptible to the tested antimicrobials, emerging macrolide resistance was detected in three Australian states and requires continued monitoring.

The attributable fraction of respiratory syncytial virus among patients of different ages with influenza-like illness and severe acute respiratory illness in a high HIV prevalence setting, South Africa, 2012-2016

ObjectivesThe detection of respiratory syncytial virus (RSV) in upper airway samples does not necessarily infer causality of illness. We aimed to calculate the attributable fraction (AF) of RSV in clinical syndromes across age groups. MethodsUsing unconditional logistic regression models, we estimated the AF of RSV-associated influenza-like illness (ILI) and severe acute respiratory illness (SARI) cases by comparing RSV detection prevalence among ILI and SARI cases to those of healthy controls in South Africa, 2012-2016. The analysis, stratified by HIV serostatus, was conducted in the age categories <1, 1-4, 5-24, 25-44, 45-64, and ≥65 years. ResultsWe included 12,048 individuals: 2687 controls, 5449 ILI cases, and 5449 SARI cases. RSV-AFs for ILI were significant in <1, 1-4, 5-and 24, 25-44-year age groups: 84.9% (95% confidence interval [CI] 69.3-92.6%), 74.6% (95% CI 53.6-86.0%), 60.8% (95% CI 21.4-80.5%) and 64.1% (95% CI 14.9-84.9%), respectively. Similarly, significant RSV-AFs for SARI were 95.3% (95% CI 91.1-97.5) and 83.4% (95% CI 70.9-90.5) in the <1 and 1-4-year age groups respectively. In HIV-infected persons, RSV was significantly associated with ILI cases vs controls in individuals aged 5-44 years. ConclusionHigh RSV-AFs in young children confirm RSV detection is associated with severe respiratory illness in South African children, specifically infants. These estimates will assist with refining burden estimates and cost-effectiveness models.

Organic-Inorganic Hybrid Nanocomposites for Nanotheranostics: Special Focus on Preventing Emerging Variants of SARS-COV-2.

The worldwide emerging cases of various respiratory viral diseases and the current escalation of novel coronavirus disease (COVID-19) make people considerably attentive to controlling these viruses through innovative methods. Most re-emerging respiratory diseases envelop RNA viruses that employ attachment between the virus and host cell to get an entry form using the host cell machinery. Emerging variants of COVD-19 also bring about a constant threat to public health as it has wide infectivity and can quickly spread to infect humans. This review focuses on insights into the current investigations to prevent the progression of incipient variants of Severe Acute Respiratory Syndrome Coronavirus (SARS-COV-2) along with similar enveloped RNA viruses that cause respiratory illness in humans and animals. Nanotheranostics is a trailblazing arena of nanomedicine that simultaneously helps prevent or treat diseases and diagnoses. Nanoparticle coating and nanofibers were extensively explored, preventing viral contaminations. Several studies have proven the virucidal activities of metal nanoparticles like copper, silver, and titanium against respiratory viral pathogens. Worldwide many researchers have shown surfaces coated with ionic nanoparticles like zinc or titanium act as potent antiviral agents against RNA viruses. Carbon nanotubes, quantum dots, silica nanoparticles (NPs), polymeric and metallic nanoparticles have also been explored in the field of nanotheranostics in viral detection. In this review, we have comprehensively discussed different types of metallic, ionic, organic nanoparticles and their hybrids showing substantial antiviral properties to stop the progression of the novel coronavirus disease focused on three key classes: prevention, diagnostics, and treatment.

Genomic profiling of Pasteurella multocida isolated from feedlot cases of bovine respiratory disease

Pasteurella multocida causes a range of diseases in many host species throughout the world, including bovine respiratory disease (BRD) which is predominantly seen in feedlot cattle. This study assessed genetic diversity among 139 P. multocida isolates obtained from post-mortem lung swabs of BRD-affected feedlot cattle in four Australian states: New South Wales, Queensland, South Australia, and Victoria during 2014–2019. Whole-genome sequencing (WGS) was used to determine capsular serogroup, lipopolysaccharide genotypes, multi-locus sequence types and phylogenetic relationships. Two capsular types (A and D), with most isolates (132/139; 95%) belonging to type A; and three lipopolysaccharide (LPS) genotypes were identified (L1 [6/139; 4.3%], L3 [124/139; 89.2%] and L6 [9/139; 6.4%)]). Multi-locus sequence types (STs) ST9, ST13, ST17, ST20, ST36, ST50, ST58, ST79, ST124, ST125, ST132, ST167, ST185, ST327, ST394, and three novel STs [ST396, ST397, and ST398] were identified, with ST394 (59/139; 42.4%) and ST79 (44/139; 32%) the most prevalent in all four states. Isolates displaying phenotypic resistance to single, dual or multiple antibiotics (macrolide, tetracycline and aminopenicillins) were predominantly ST394 (23/139; 17%). Laterally mobile elements identified in the resistant ST394 isolates included small plasmids, encoding macrolide and/or tetracycline resistance, distributed in all states; and chromosomally located integrative conjugative elements (ICEs) (4 ST394 and 1 ST125) from the same Queensland feedlot. This study highlights the genomic diversity, epidemiological relationships and AMR associations in bovine P. multocida isolates from Australia and provides insight into the unique ST prevalence compared to other major beef-producing countries.

The Evaluation of the German SARS-CoV-2 Test Strategy - A Multifactorial View

With SARS-CoV-2 in 2019 a coronavirus started circulating, for which the population showed no specific defense mechanisms of the immune system due to its clear distinction from the previously circulating coronavirus strains. Nevertheless, in 2021 there was a significant decrease in respiratory infections with a simultaneous significant increase in pandemic-related SARS-CoV-2 infections found. There is also a reduction in reported cases of respiratory diseases, especially in the pandemic year 2021. The aim of this study is to show optimizations in the test strategy during a pandemic and thus derive the improvement of civil protection. For Evaluation the data of GrippeWeb, the RKI’s Survstat® tool and the RKI’s reporting data on the new coronavirus were used. In addition, an evaluation of billing data from the EBM from 2017 to 2022 for the GOP 32816 as well as an evaluation of data on sick leave and illness statistics from 2019 to 2021 and the consideration of inpatient and outpatient health costs based on the data requested in writing from the Federal Ministry of Health was performed. The data from the Influenza Working Group shows an average of 300,000 annual reports for ARI per year. In 2019 it increased to 1,985,985 reports, in 2020 (5,453,017) and in 2021 to 29,681,158. There is also a correlation between the SARS-CoV-2 test frequency and the positive results, as well as an increase in the previously 6% positive rate for SARS-CoV-2 to over 50% in 2022. At the same time decreases the medical burden due to acute respiratory diseases (ARI) contrary to the increase of the acute respiratory diseases reported to the RKI with 2684%. What has been neglected so far is that corona viruses (HCoV) have been responsible for around 5-10% of acute respiratory infections for decades. The comprehensive Covid-19 control measures, including the obligation to wear masks, apparently had no significant impact on reducing the spread of Covid-19, since there was also no decrease in infections with the adenovirus or RS virus in 2020 and 2021. Furthermore, an infection positive rate should not be used as a criterion for infection avoidance strategies and the recording of test results should always be validated and controlled. Only the testing of symptomatic persons should be remunerated and only these validated test results should be considered in the registration. In addition, the DIVI register for the inpatient area with recording of the main admission diagnosis and the data from the electronic transmission of sick notes to the health insurance companies for the outpatient area could be used in real time to decide on containment measures in the context of the pandemic

Respiratory virus infections of the lower respiratory tract elevate bronchoalveolar lavage eosinophil fraction: a clinical retrospective study and case review

BackgroundEosinophilic airway inflammation caused by respiratory virus infection has been demonstrated in basic research; however, clinical investigations are lacking. To clarify the extent to which respiratory virus infection induces airway eosinophilic inflammation, we reviewed the results of bronchoalveolar lavage (BAL) and respiratory virus testing performed at our hospital.MethodsAmong the BAL procedures performed at the University of the Ryukyu Hospital from August 2012 to September 2016, we collected cases of acute respiratory disease in which multiplex polymerase chain reaction (PCR) was used to search for respiratory viruses. The effect of respiratory virus detection on BAL eosinophil fraction was analyzed using statistical analysis. A case study was conducted on respiratory virus detection, which showed an elevated BAL eosinophil fraction.ResultsA total of 95 cases were included in this study, of which 17 were PCR-positive. The most common respiratory virus detected was parainfluenza virus (eight cases). The PCR-positive group showed a higher BAL eosinophil fraction than the PCR-negative group (p = 0.030), and more cases had a BAL eosinophil fraction > 3% (p = 0.017). Multivariate analysis revealed that being PCR-positive was significantly associated with BAL eosinophil fraction > 1% and > 3%. There were nine PCR-positive cases with a BAL eosinophil fraction > 1%, of which two cases with parainfluenza virus infection had a marked elevation of BAL eosinophil fraction and were diagnosed with eosinophilic pneumonia.ConclusionsCases of viral infection of the lower respiratory tract showed an elevated BAL eosinophil fraction. The increase in eosinophil fraction due to respiratory virus infection was generally mild, whereas some cases showed marked elevation and were diagnosed with eosinophilic pneumonia. Respiratory virus infection is not a rare cause of elevated BAL eosinophil fraction and should be listed as a differential disease in the practice of eosinophilic pneumonia.